Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study

  • Haematologica. 2021 Mar 1;106(3):859-862. doi: 10.3324/haematol.2019.224535.
Franck Morschhauser  1 ,  Kamal Bouabdallah  2 ,  Stephan Stilgenbauer  3 ,  Catherine Thieblemont  4 ,  Sophie de Guibert  5 ,  Florian Zettl  6 ,  Lawrence M Gelbert  7 ,  Kellie P Turner  8 ,  Siva Rama Prasad Kambhampati  8 ,  Li Li  8 ,  Lily Q Li  8 ,  Sean Buchanan  8 ,  Susana Barriga  8 ,  Melissa M Bear  8 ,  Martin Wilhelm  9 ,  Georg Hess  10
Affiliations
  • 1. Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France.
  • 2. Hopital Haut-Levêque, Centre Hospitalier Regional Universitaire de Bordeaux, Pessac, France.
  • 3. Internal Medicine III, Ulm University, Ulm, Germany.
  • 4. Hemato-Oncology Department, Hôpital Saint-Louis and Diderot University, Paris, France.
  • 5. Hôpital de Pontchaillou, Rennes, France.
  • 6. Universitätsmedizin Göttingen, Göttingen, Germany.
  • 7. LMG PharmaTech, LLC., Indianapolis, Indiana, USA.
  • 8. Eli Lilly and Company, Indianapolis, Indiana, USA.
  • 9. Klinikum Nürnberg Nord, Nürnberg, Germany.
  • 10. Universitätsmedizin Mainz, Mainz, Germany.
PMID: 32381571 DOI: 10.3324/haematol.2019.224535
Products